Enantioselective synthesis and evaluation of 4-styryldihydropyrimidin-2-thiones as anti-proliferative agents

被引:0
|
作者
Han Yu
Guoyong Dai
Qiu-Rui He
Jiang-Jiang Tang
机构
[1] Shanghai Institute of Technology,School of Chemical and Environmental Engineering
[2] Northwest A&F University,Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy
来源
关键词
DHPMs; Organocatalytic; Biginelli reaction; Anti-proliferative activity;
D O I
暂无
中图分类号
学科分类号
摘要
A series of novel chiral 4-styryldihydropyrimidin-2-thiones were prepared with high yields and enantioselective by a Biginelli reaction. In the condensation reaction, substituted cinnamaldehyde, thiourea, and β-ketoester were organocatalyzed to afford 4-styryldihydropyrimidin-2-thiones 4a–v using self-assembled methanoproline-thiourea as catalysts. Anti-proliferative activity of these 4-styryldihydropyrimidin-2-thiones was tested against the HepG2 and PC-3 cells. Among all the tested compounds, 4e, 4k, and 4s bearing CF3- groups at styryl group displayed moderate anti-proliferative activity with IC50 ranged between 29.3–38.5 μM. The structure–activity relationship showed that substituents (R1) on the C-4 styryl ring of 4-styryldihydropyrimidin-2-thiones and R3 at ester group affected the anti-proliferative activity, yet R2 at C-6 position had little influence for anti-proliferative activity.
引用
收藏
页码:787 / 795
页数:8
相关论文
共 50 条
  • [31] PLK4 Inhibitors of novel structure as potent anti-proliferative agents
    Pauls, Henry W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [32] Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity
    Gromek, Samantha M.
    deMayo, James A.
    Maxwell, Andrew T.
    West, Ashley M.
    Pavlik, Christopher M.
    Zhao, Ziyan
    Li, Jin
    Wiemer, Andrew J.
    Zweifach, Adam
    Balunas, Marcy J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5183 - 5196
  • [33] Trisubstituted barbiturates and thiobarbiturates: Synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative agents
    Figueiredo, Joana
    Serrano, Joao L.
    Cavalheiro, Eunice
    Keurulainen, Leena
    Yli-Kauhaluoma, Jari
    Moreira, Vania M.
    Ferreira, Susana
    Domingues, Fernanda C.
    Silvestre, Samuel
    Almeida, Paulo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 829 - 842
  • [34] Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agents
    Dheer, Divya
    Behera, Chittaranjan
    Singh, Davinder
    Abdullaha, Mohd
    Chashoo, Gousia
    Bharate, Sandip B.
    Gupta, Prem N.
    Shankar, Ravi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [35] Pharmacophore mapping studies on pyrazoles as anti-proliferative agents
    Sharma, Vandana
    Sharma, Vikas
    Kumar, Pradeep
    Kumar, Vipin
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 27 (06) : 1851 - 1855
  • [36] Synthesis of new 1,2,3-triazole linked benzimidazole molecules as anti-proliferative agents
    Sahay, Ishani I.
    Ghalsasi, Prasanna S.
    SYNTHETIC COMMUNICATIONS, 2017, 47 (08) : 825 - 834
  • [37] Development of geminin mimetics as novel anti-proliferative agents
    Stoeber, K
    Eward, KL
    Kingsbury, SR
    Okorokov, AL
    Madge, D
    Selwood, DL
    Williams, GH
    JOURNAL OF PATHOLOGY, 2005, 207 : 6 - 6
  • [38] ANTIOXIDANTS AS POSSIBLE ANTI-PROLIFERATIVE AGENTS FOR PANCREATIC CANCER
    Chowdhury, Parimal
    GASTROENTEROLOGY, 2019, 156 (06) : S758 - S758
  • [39] Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity
    Dodou, K
    Anderson, RJ
    Lough, WJ
    Small, DAP
    Shelley, MD
    Groundwater, PW
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (13) : 4228 - 4237
  • [40] Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation
    Ghobish, Sarah A.
    Mohamed, Khaled O.
    Farag, Nahla
    Farag, Doaa B.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 293 - 308